Ukrainian Pharmaceutical Market Monthly - Upharmacia - Apr 2019

U P H A R M A C I A
41 2019Issue April
Ukrainian Pharmaceutical Market Monthly
Photo by Oleg Stelmakh on Skyandmethod.com

U P H A R M A C I A
Ukrainian Pharmaceutical Market Monthly
DISCLAIMER
These publications have been prepared by the research
department of UPharma Consulting (“UPC”). It is provided
to our clients and industry stakeholders for information
purposes only, and UPC makes no express or implied
warranties, and expressly disclaims all warranties of
merchantability or fitness for a particular purpose or use
with respect to any data included in this publication. UPC
will not treat unauthorized recipients of this report as its
clients.
The information contained in this publication has been
obtained from sources that UPC’s research group believes to
be reliable, but UPC does not represent or warrant that it is
accurate or complete. UPC is not responsible for, and makes
no warranties whatsoever as to, the content of any thirdparty
web site accessed via a hyperlink in this publication and such
information is not incorporated by reference.
COPYRIGHTS & AUTHORS
All rights reserved. No part of this publication may be
reproduced in any manner without the prior written
permission of UPharma Consulting.
UPharma Consulting LLC is registered in Ukraine, Kyiv,
40th Hlybochytska str., building F, office 401. Additional
information regarding this publication will be furnished
upon request.
UPharma Consulting is a professional consulting company,
operating in the Life Sciences sector. We deliver best
global practices in market knowledge, people management,
marketing and strategy for Pharma and Healthcare in the
CIS/CEE.
41 2019Issue April

Issue 41 April 2019 page 01
ECONOMY
02 MACROECONOMIC INDICATORS
Reporting period: April 2019
03 ECONOMY NEWS
Graphs and trends
HEALTHCARE
07 HEALTHCARE NEWS
Updates and MOH releases
PHARMA MARKET
04 PHARMA MARKET INDICATORS
05 PHARMA MARKET NEWS
06 REGULATORY UPDATES
Regulation updates in April 2019
CIS PHARMA NEWS
08 REGIONAL NEWS
News from CIS countries
09 CIS PHARMA REPORTS
New reports on the CIS markets

ECONOMY
MACROECONOMIC INDICATORS
2018 2018
FY
2019
Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
MACROECONOMIC INDICATORS
Q1 Q2 Q3 Q4 Q1
GDP ($ bn) 25.642 30.839 36.347
real GDP growth, y-o-y (%) 3.1% 3.8% 2.8%
Export ($ bn) 4.06 4.02 4.01 3.74 3.62 4.04 3.64 4.25 4.45 4.10 47.31 4.06 3.89 4.32
growth, y-o-y (%) -1.2% 21% 15% 12% 13% 10% -3.4% 10% 3.4% 4.6% 9.4% 9.1% 6.6% 6.5%
Import ($ bn) 4.37 4.28 4.43 4.33 4.99 4.92 4.99 5.75 5.38 5.08 56.81 4.15 4.60 4.92
growth, y-o-y (%) 0.0% 15% 16% 9% 24% 16% 16% 26% 14% 3.4% 15% 2.2% 8.7% 12.7%
Industrial Prod. Sales ($ bn) 8.29 7.46 7.58 7.48 7.50 7.16 7.11 7.96 8.28 8.83 92.16 7.87 7.41
growth, y-o-y (%) 20% 26% 21% 19% 19% 8% 7% 10% 8% 8% 14% 9.6% 1.3%
Retail Turnover ($ bn) 2.06 2.03 1.94 2.05 2.09 1.96 1.99 2.08 2.28 2.57 24.52 2.05 1.92 2.26
growth, y-o-y (%) 28% 22% 0.2% 15% 7% -6% -3% 5% 15% 7% 11% 17.7% 10.3% 9.8%
Unemployment Rate (%) 1.4 1.2 1.2 1.2 1.2 1.1 1.1 1.1 1.2 1.3 1.2
Average Salary ($) 318 324 333 349 350 327 321 328 328 389 327 331 347 381
Consumer Price Index 113.2 113.1 111.7 109.9 108.9 109.0 108.9 109.5 110.0 109.8 111.0 109.2 108.8 108.6
GfK Consumer Sentiment Index 57.7 61.3 62.9 65.6 61.8 60.3 62.6 56.9 59.8 62.2 60.5
OFFICIAL CURRENCY EXCHANGE RATE
UAH / USD 26.3 26.2 26.2 26.2 26.4 27.5 28.2 28.1 27.9 27.8 27.2 27.9 27.2 26.9
UAH / EUR 32.5 32.1 31.0 30.7 30.8 31.7 32.9 32.3 31.8 31.6 32.1 31.8 30.8 30.4
26.3
26.2
26.2 26.2 26.4
27.5 28.2 28.1 27.9 27.8 27.9 27.2 26.9
32.5
32.1 31.0 30.6 30.8
31.7
32.9 32.3 31.8 31.6 31.8
30.8
30.4
2018 2019
UAH/USD UAH/EUR
OFFICIAL CURRENCY EXCHANGE RATES
8.29
7.46 7.58 7.48 7.50
7.16 7.11
7.96
8.28
8.83
7.87
7.41
2.06 2.03 1.94 2.05 2.09 1.96 1.99 2.08
2.28
2.57
2.05 1.92
2.26
0
1
2
3
4
5
0
1
2
3
4
5
6
7
8
9
10
2018 2019
RetailTurnoverofEnterprises(USD,Bn)
IndustrialProductionSales(USD,Bn)
Industrial Production Sales Retail Turnover of Enterprises
INDUSTRIAL PRODUCTION RETAILS SALES
Sources: State Statistics Service of Ukraine, UPharma Consulting, National Bank of Ukraine, ICU
113.2 113.1
111.7
109.9
108.9 109.0 108.9 109.5 110.0 109.8 109.2 108.8 108.6
108.1 108.3 108.3 107.8 107.2 107.2
107.9 107.8 107.6 107.4 107.7
106.5
107.3
100
105
110
115
2018 2019
Total CPI, % y-o-y Pharma products CPI, % y-o-y
TOTAL CPI VS PHARMA PRODUCTS CPI
Reporting period: Mar 2019
Ukrainian Economy In March
- The y-o-y Consumer Price Index amounted 108.6 in
Mar decreasing slightly vs Feb.
- The UAH strengthened against both EUR and USD.
UAH/USD exchange rate amounted to 26.9, UAH/EUR
- to 30.4.
- Ukrainian export of goods grew by 6.5% y-o-y in
Mar, while import rose 12.7% y-o-y. Trade balance was
negative and amounted USD 599m vs USD 707m in
Feb.
- An average nominal monthly salary increased by
9.7% m-o-m in Mar to USD 381 (UAH 10,237).

ECONOMY
The World Bank has worsened the
forecast for the growth of Ukraine’s GDP
in 2019 to 2.7% from 2.9%. The Bank retained the
forecast for Ukraine’s GDP growth in 2020 at the level of
3.4%, while for 2021 lowered to 3.7% from 3.8%. Source
Ukraine’s industrial output rose 2.1%
y-o-y in Mar, after a 1.8% y-o-y fall in Feb, due to
restored growth in manufacturing (5.0% y-o-y) and
continuing growth in mining (1.8% y-o-y). Food production
advanced 7.3% y-o-y and metallurgical production surged 8.9% y-o-y. In
1Q2019, industrial output declined 0.9% y-o-y. Source
The EBRD is going to double investments
in Ukraine’s economy in 2019 to USD
1bn. However, the Head of the Ukrainian office of
the EBRD noted the importance of consistency and
predictability of future economic policy of the government as well as
continuation of cooperation with the IMF. Source
Resolving the war in Donbas
and fight against corruption will
be the main of goals of the newly elected
President Volodymyr Zelenskiy. The new
president is also going to introduce a 5% tax amnesty
starting 2020, create the legal framework for national and
local referenda and petitions, recalling MPs, and impeaching
president. However, achieving these goals will require
support of the Parliament. Mr. Zelenskiy may consider
announcing of early elections, if the cooperation with the
Rada is unproductive. Source
Ukrainian President signed
the newly created bankruptcy
code, legislation that is aimed to better
protect the interests of creditors in relation
to their insolvent debtors. The law was adopted by
parliament in Oct 2018, simplifying the procedures of debt
restructuring, debtor financial recovery and liquidation,
as well as creating a bankruptcy procedure for individual
debtors. Source
Real disposable income of
Ukraine’s citizens rose 9.9%
y-o-y in 2018, accelerating from 7.4%
y-o-y growth in 2017, the State Statistics
Service reported. Average disposable monthly income
per individual increased to UAH 4,826 (USD 177) from
UAH 3,814 (USD 143) in 2017. Nominal gross income of
individuals rose 21.4% y-o-y, driven mostly by accelerating
wages (26.2% y-o-y) and social income (18.0% y-o-y). Source
The IMF kept unchanged its
2019 forecast for Ukraine’s GDP
at 2.7% growth
In 2020-2024, Ukraine’s GDP growth will
range from 3.1% to 3.3% y-o-y, the IMF predicted. At the
same time, the IMF worsened its forecast of 2019 consumer
inflation to 7.0% YTD y-o-y from 6.2% YTD. It expects
consumer inflation to gradually slow down to 5.0% YTD in
2023. Source
The ratio of Ukraine’s total
state debt to GDP will decrease
to 62% by the end of 2019, the
IMF forecasted. This figure will continue
to decline in the following years and will amount 43.7% in
2024. Source
ECONOMIC NEWS
APRIL 2019

PHARMA MARKET
PHARMA MARKET INDICATORS
2018 2018
FY
2019
PHARMACEUTICAL INDUSTRY INDICATORS
Export of Pharma Products ($mio) 17.1 16.3 16.6 25.2 13.3 17.9 19.9 22.2 17.1 25.8 216.3 9.6 22.5 23.7
growth, y-o-y -22% 33% 17% 24% -6.3% 37% 19% 53% -15% 1.9% 11.8% 0.3% 46% 39%
Import of Pharma Products ($mio) 149.9 155.3 165.7 157.2 181.2 133.6 156.7 185.3 162.9 206.8 1946.8 148.3 165.2 160.9
growth, y-o-y -0.5% 33% 14% 0.3% 20% -11% 6.9% 27% -8% 2.3% 10% 7.4% 6.9% 7.3%
Retail Sales, values ($mio) 286.9 265.4 258.8 252.0 254.8 255.7 270.2 290.5 299.9 327.3 3264.7 313.3 299.1 323.8
growth, y-o-y 53% 26% 19% 22% 21% 20% 14% 16% 13% 20% 19.6% 30% 14% 12.9%
Retail Sales, volumes (units mio) 150.8 144.9 143.6 137.6 139.3 142.3 149.2 151.5 151.0 161.7 1755.1 153.2 140.5 148.8
growth, y-o-y 24% 8% 5% 4% -0.1% 6% 2% 3.7% -0.4% 11% 4.2% 8.8% -1.3% -1.3%
Average Cost of a Pack $ 1.90 1.83 1.80 1.83 1.83 1.80 1.81 1.92 1.99 2.02 1.86 2.05 2.13 2.18
growth, y-o-y 24% 17% 14% 17% 21% 14% 12% 12% 13% 13% 15.4% 20% 16% 14%
CPI, Pharma Products 108.1 108.3 108.3 107.8 107.2 107.2 107.9 107.8 107.6 107.4 107.6 107.7 106.5 107.3
Share of Local Companies
(%, values)
43.5 43.5 43.5 43.6 43.6 42.7 43.0 43.2 43.7 43.8 43.3 43.7 44.2
Share of Local Companies
(%, volumes)
74.9 75.2 75.4 75.7 75.9 75.3 73.9 73.4 73.0 72.9 56.7 73.2 73.7
286.9
265.4 258.8 252.0 254.8 255.7
270.2
290.5
299.9
327.3
313.3
299.1
323.8
150.8
144.9 143.6
137.6 139.3 142.3
149.2 151.5 151.0
161.7
153.2
140.5
148.8
100
120
140
160
180
200
220
240
100
140
180
220
260
300
340
2018 2019
Salesinvolumes(miounits)
Salesinvalues(mioUS$)
Values, mio USD Volumes, mio units
RETAIL SALES OF PHARMACEUTICAL PRODUCTS
Sources: State Statistics Service of Ukraine, UPharma Consulting, apteka.ua
17.1 16.3 16.6
25.2
13.3
17.9 19.9 22.2
17.1
25.8
9.6
22.5 23.7
149.9 155.3
165.7
157.2
181.2
133.6
156.7 185.3
162.9
206.8
148.3
165.2
160.9
0
30
60
90
120
150
180
210
0
10
20
30
40
50
60
70
80
2018 2019
Import(USD,mio)
Export(USD,mio)
Export Import
UKRAINE'S INTERNATIONAL TRADE IN PHARMA PRODUCTION
1.90 1.83 1.80 1.83 1.83 1.80 1.81 1.92 1.99 2.02 2.05 2.13 2.18
24%
17% 14% 17%
21%
13% 12% 12%
13% 13%
20%
15%
14%
0%
5%
10%
15%
20%
25%
30%
1.3
1.4
1.5
1.6
1.7
1.8
1.9
2.0
2.1
2.2
2018 2019
y-o-ygrowth,%
WACP($)
Weighted Average Cost of a Pack, USD WACP, % y-o-y
WEIGHTED AVERAGE COST OF A PACK
43.2 43.5 43.5 43.4 43.5 43.6 42.7 43.0 43.2 43.7 43.8 43.7 44.2
56.8 56.5 56.6 56.6 56.5 56.4 57.3 57.0 56.8 56.3 56.2 56.3 55.8
Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
2018 2019
Local Foreign
SHARES OF LOCAL/FOREIGN MANUFACTURERS (%,VALUES)
Ukrainian Pharmaceutical Market in
March
- The retail sales of drugs on the Ukrainian
Pharmaceutical market increased by 12.9% y-o-y in
values and decreased by 1.3% y-o-y in volumes.
- Export of pharamceuticals from Ukraine grew by
39% y-o-y to USD 23.7m. Import of pharmaceuticals to
Ukraine rose by 7.3% y-o-y to USD 160.9m.
- The Consumer Price Index of pharma products
slightly increased vs Feb to 107.3.
- The average cost of a pack enhanced by 14% y-o-y to
USD 2.18.
Reporting period: Mar 2019

PHARMA MARKET
Darnitsa Transforms
Product Cycle Process and
Quality Management
Pharmaceutical company Darnitsa in cooperation with the
Spanish company Stratesys is implementing the project on
the digital transformation of the process of managing the
life cycle of a pharmaceutical product and the processes
of quality management. Implementation of the electronic
document management system should ensure the
effectively operation of the drug development processes,
increase staff productivity, and reduce the risks associated
with the qualitative characteristics of these processes. As
a result, the company plans to reduce the time of launching
new drugs onto the market and ensure the integrity and
reliability of processes that cover the life cycle of a drug.
The implementation of a coherent and integrated
document management system for document and process
management that accompanies the life cycle of drugs will
give the ability to handle a huge array of information and
data being generated. It should also give the opportunity to
work on the development and research of drugs at a higher
quality level, complying with all regulatory requirements.
“We have passed a log way before choosing partners and
the configuration itself,” the General Director of Darnitsa
Andriy Obrizan stated. “This is a challenge for us. We are
being watched not only by our stuff, but by the whole
market. In 15 months, we will become a benchmark in the
field of drug dossier document management and a quality
system management in Ukraine and beyond.”
The project of electronic document management is being
implemented by a joint team of specialists from Darnitsa,
Stratesys and technology experts from SAP and OpenText.
The project is a part of the transformational processes
in the company aimed at improving the processes of
development and production of pharmaceutical products
by optimizing the processes of life cycle management of
drugs.
Farmak Summarized the
Results of 2018
Ukraine’s leading pharmaceutical company Farmak summed
up the results of its activity in 2018. In the reported period,
the company’s income increased by 8.8% y-o-y vs 2017
to UAH 6.6bn. The net profit increased by UAH 211m. The
company payed UAH 658m taxes in 2018, which was 25%
more than in 2017.
In 2018, Farmak launched 17 new brands in 34 SKUs.
Farmak was the leading company in the program “Affordable
drugs” by consumed daily doses. 26 of Farmak’s are
included in the reimbursement list (7 are fully reimbursed,
19 – partially).
Sales on the external markets make up 25.8% of the total
sales. Farmak continues to develop its export potential
and exports its products to more than 20 countries outside
Ukraine. In 2018, the company opened new markets of
Australia, Greece and Libya. Farmak took the 3rd position in
the market of Uzbekistan.
Farmak’s capital investments amounted to UAH 623m,
which is 30% more than in the previous year. These funds
were funneled to a new pill production and modernization of
the warehouse complex. Construction of the new production
of liquid medicinal products has also begun.
“In 2019, we are planning to increase investment to an
unprecedented amount of UAH 1.045bn,” the company’s
CEO Volodymyr Kostiuk said. “These funds will be allocated
to completion of the new tablet production, the project of
liquid drugs, a new office-laboratory complex, information
technologies, quality assurance and purchase of laboratory
equipment. Farmak continues cooperation with the
international financial institutions e.g. EBRD within the
framework of investment projects. Farmak also started
developing new therapeutic segments, such as asthma,
psychiatry and oncology.”
Darnitsa Admitted to Be
One of the Most Expensive
Brands in Ukraine
Ukrainian pharmaceutical company Darnitsa was placed
4th in the rating of the Most Expensive Brands in Ukraine
prepared by Korresopndent magazine. The estimated
value of the brand amounted USD 172.2m, which is almost
16% higher than last year. In assessing the brand, the key
macroeconomic indicators of Ukraine and the advertising
activity of the participants were taken into account. The
drafters did not consider multinational brands, as well as
those that do not work with retail customers.
“In 2018, Darnitsa’s net profit rose by 31.3% y-o-y,” the
Chairman of the Executive Board of the company Dmytro
Shymkiv said. “Our goal is to build the international
company guided by global standards”.
In 2018, Novoye Vremya magazine assessed Darnitsa’s
brand at USD 8m, ranking it the 81st brand is the Top-100
rating. Another Ukrainian pharma company Farmak was
placed 78th with brand costing USD 8.8m.
In 2018, Darnitsa was the 4th company on the retail drug
market losing the 3rd position it had taken in 2016 and
2017. The market share of the company amounted 3.90% vs
4.12% in 2017.
PHARMACEUTICAL MARKET NEWS
APRIL 2019

PHARMA MARKET
REGULATORY UPDATES
APRIL 2019
The MOH Issued a Draft Order on
Reference Pricing for Medicines
On April 9, the MOH of Ukraine published a draft order “On
certain issues of reference pricing for medicines included in
the National List of Essential Medicines and procured using
budget funds”. The document was developed in pursuance
of the resolution of the Cabinet of Ministers of Ukraine “On
reference pricing for some medicines procured using budget
funds”, adopted by the Government last week.
Recall that from July 1, 2019, Ukraine will introduce state
regulation of prices for some INNs that are included in the
National List of Essential Medicines. For such INNs, which
will be procured using budget funds, the Ministry of Health
will establish marginal wholesale prices. Drugs the cost of
which will exceed such prices cannot be procured at the
expense of the state.
The draft order is proposed to approve:
»» Procedure for forming the List of Medicinal Products
included in the National List of Essential Medicines,
and for which the maximum wholesale prices are set;
»» The procedure for calculating the maximum wholesale
prices for medicinal products contained in the List
of Medicinal Products included in the National List
of Essential Medicines and for which the maximum
wholesale prices are set.
Provided by
Provided by
Medical Drugs’ Advertising Status
Regulation is Changed
European Business Association is pleased to announce that
the legislation gap related to the technical impossibility
to change the medical drugs advertising status is filled in.
Now the possibility of changing the status is established
not only as a result of the medical drugs’ renewal procedure,
but also the variations procedure.
Medical drug is a ‘live’ product. As a result of the confirmed
changes to one or another “parameter” of a medical drug
the appropriate changes are made to the registration
materials (variations procedure). Such changes may directly
affect the advertising status of a drug as in accordance
with the defined Criteria. Up to now there were no legal
grounds to allow changes in the State Register of Drugs of
Ukraine (Register) accordingly, as based on the extended or
narrowed list of indications.
As a result of amendments to the Cabinet of Ministers of
Ukraine Resolution №376, the possibility of changing the
medical drugs advertising status in the Register should
be ensured just in the right time where there is a relevant
evidence, which is confirmed by the State Expert Center
recommendations followed by the relevant decision of the
MOH of Ukraine.
We express our gratitude to the MOH for the first step in
solving the issue and are looking forward to its further
implementation in practice.

HEALTHCARE
HEALTHCARE NEWS
APRIL 2019
Health Ministries of Ukraine and the US to
Sign Cooperation Memorandum
The MOH of Ukraine and the United States Department of
Health and Human Services (HHS) are going to sign the
Memorandum on cooperation in the areas of treatment and
prevention of oncological diseases, clinical and scientific
research in the oncology field, general vaccination and
vaccination for the prevention of papillomavirus. The
corresponding issue was discussed during the meeting
between the acting Head of the MOH Ulana Suprun and the
Head of HHS Alex Azar.
“Our international partners are closely watching the
transformation of the health care system in Ukraine and are
pleasantly surprised by the results,” Mrs. Suprun said.
Electronic Prescription was Launched in
Ukraine
Since Apr 1, Ukrainian patients are able to receive drugs within
the government’s reimbursement program “Affordable drugs”
through electronic prescriptions. The system will work only in
those pharmacies that has concluded the contract with the
National Health Service of Ukraine (NHSU) to participate in the
reimbursement program.
Shortly after the introduction of the innovation, a lot of
limitations were revealed by patients. Users complained about
long time required for processing the prescription and issuing
it in clinics. Moreover, not all the pharmacies sell drugs for
e-prescriptions. Spokesman of the e-Health Association and
the Head of “Clinic without queue” project Andriy Zayets stated
that the limitations were expected and all the defects would be
fixed within the month.
The reimbursement program “Affordable drugs” was launched
on Apr 1, 2017. Since then, above 6ths. pharmacies throughout
the country have joined the program. On Apr 1, 2019, the
administration of the program was transmitted form the MOH
to the NHSU.
In its report issued on Apr 17, the WHO regional office for
Europe positively assessed the work of the “Affordable
drugs” program. According to the estimates, the program has
improved the access of Ukrainians to treatment and allowed to
decrease drug prices.
Basic Product of Single Information
System of Transplantation Presented
Functional of the Unified State Information System of
Transplantation (USIST) was presented by its developers. The
system covers all key logistic processes of the daily operation
of the registry: managing data from donors and patients,
managing requests, records of transplantations carried out
etc. Currently, the USIST includes 8 registers. The platform
with the register of stem cell donors will be attached to it later.
The system has both standard and mobile versions.
Functional of the USIST is constructed in a way that allows
registries to interact with each other through algorithms of
automatic search and correspondence of a donor-recipient
pair. The decision on determining a recipient of an organ will
not depend on the human factor.
In May 2018, the Parliament approved the Law on
transplantation, which should have come into force since Jan
1, 2019. However, the government postponed the launch of
the transplantation system in Ukraine to Jan 1, 2020 in order
to develop the needed legislative act as well as implement the
single information system.
Zelenskiy will Support Further
Implementation of Medical Reform, his
Advisor
Newly elected president of Ukraine Volodymyr Zelenskiy will
support the course for the continuation of the initiated reform
of the health care system, his advisor, a famous pediatrician
Doctor Eugene Komarovsky stated.
“I am a supporter of the strategic course on the healthcare
reform being implemented today,” Mr. Komarovsky said. “I
see real risks to implementation of this course and this is the
main cause that made me respond positively to V. Zelenskiy’s
request to become his advisor.”
Dr. Komarovsky noted that if president Zelenskiy takes
advantage of his advice, he will support the principles
of transformation of the health financing system that is
happening now and will help to speed up the health care
reform in hospitals. New president will also do everything in
his power to ensure the implementation of the rule of law on
health care financing at 5% of GDP.
At the same time, Dr. Komarovsky believes that, having
become president, Zelenskiy will generally support “the team
of reformers who are now implementing the medical reform”,
“but the attitude towards the team as a whole and its individual
members may change depending on the results of their work.”
On Apr 18, Volodymyr Zelenskiy presented his team, which
should become a base of his future Administration, while some
of the members may take some posts in the new government.
However, Mr. Zelenskiy has not made any statements on
possible candidates for the post of the Minister of Heath.
However, before the elections he said he positively assessed
the efforts of Ulana Suprun to transform the healthcare system
of Ukraine.

CIS PHARMA NEWS
AZERBAIJAN
Market access. Pakistani pharmaceutical
company WnsFeild Pharmaceuticals eyes to
enter the Azerbaijani market, the Director of
the company’s sales and export department stated. The
company was formed in 2007. The company exports
its products to Yemen, Afghanistan, Rwanda and other
countries.
BELARUS
Industry. Belarus company Medtechcenter
signed the memorandum with Chinese
companies Biolight Co., Ltd and Medeco
Industry Co., Ltd. on the creation of joint production
facilities for the production of medical equipment in
Belarus.
KAZAKHSTAN
E-health. On 07/04/2019, the Order of the MOH
on the new rules for drug prescription came
into force. Now, at the choice of the patient,
prescriptions can be drawn up either on paper or in the
form of an electronic document certified by e-signature of
a medical professional.
RUSSIA
Industry. Russian Direct Investment Fund,
sovereign fund of Russian Federation and
Turkish company Ronesans Holding agreed to
jointly implement a project to build 15 medical clusters
with common technological platform in the regions of
Russia.
Pipeline. Russian company BIOCAD registered the original
inhibitor of interleukin-17, developed for the treatment of
moderate and severe psoriasis. According to estimates of
the company, launching of the drug should reduce the cost
of treating severe psoriasis three times.
Market. In 3M2019, the Russian retail pharmaceutical
market increased by 1.7% vs 3M2018 to RUB 255.2bn. In
March 2019, the market fell by 5% vs March 2018 to RUB
86.9bn.
Retail trade. Retail chain Magnit is preparing to launch 300
pharmacies throughout Russia. It is going to open 2,000
pharmacies in total by the end of the year.
UZBEKISTAN
Public procurement. From 1 Jul 2019 to 31 Dec
2020, the government will hold an experiment
in the public procurement of drugs and medical
devices aimed to promotion of the Uzbek production.
The state customer will reject all applications containing
proposals for the supply of imported drugs and medical
devises, if there are two or more domestic manufacturers
of similar products (by international non-proprietary name).
PHARMA NEWS IN THE CIS REGION
APRIL 2019

CIS PHARMACEUTICAL MARKETS REPORTS
GREAT NEWS!
New! KAZAKHSTAN
PHARMACEUTICAL
MARKET OVERVIEW
4Q 2018
Distribution: digital, PDF
Historical data: 2016-2018
Forecast horizon: 2021
Contents: download
Price: EUR 500
New! UZBEKISTAN
PHARMACEUTICAL
MARKET OVERVIEW
4Q 2018
Distribution: digital, PDF
Historical data: 2016-2018
Forecast horizon: 2021
Contents: download
Price: EUR 500
reports.upharma-c.com
Fast order and delivery. Easy to purchase!
ALL OUR REPORTS ARE NOW AVAILABLE ON
THE NEW LANDING PAGE

PROFESSIONAL CONSULTING SERVICES
BUSINESS
CONSULTING
HR-
CONSULTING
MARKET
ACCESS
BUSINESS
EDUCATION
MA Deals Support / Pre-investment Due Diligence /
Commercial Audit / Business Diagnostics /
FCPA Audit / Reputational Audit
Executive Search / Recruitment /
Organizational Consulting /
Personnel Assessment
Launch Planning / Market Analysis Strategic Planning /
Regulatory Environment Audit / Business Modelling /
HEOR Pharmacoeconomics
Business Training for Pharmaceutical Companies:
Strategy / Change Management
New Launches / Marketing
+380 (44) 232 1142
+380 (44) 232 1143
upharma-c.com
mailbox@upharma-c.com
UPharma Consulting
40th
Hlybochytska str.,
building F, office 401
Kyiv, 04050,
Ukraine

Ukrainian Pharmaceutical Market Monthly - Upharmacia - Apr 2019

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Ukrainian Pharmaceutical Market Monthly - Upharmacia - Apr 2019

Similar to Ukrainian Pharmaceutical Market Monthly - Upharmacia - Apr 2019 (20)

More from Eirhub

More from Eirhub (10)

Recently uploaded

Recently uploaded (20)

Ukrainian Pharmaceutical Market Monthly - Upharmacia - Apr 2019